CN110331121A - A kind of recombinant bacterium of high yield lipopeptid and its application - Google Patents

A kind of recombinant bacterium of high yield lipopeptid and its application Download PDF

Info

Publication number
CN110331121A
CN110331121A CN201910549289.5A CN201910549289A CN110331121A CN 110331121 A CN110331121 A CN 110331121A CN 201910549289 A CN201910549289 A CN 201910549289A CN 110331121 A CN110331121 A CN 110331121A
Authority
CN
China
Prior art keywords
glu
ala
leu
val
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910549289.5A
Other languages
Chinese (zh)
Other versions
CN110331121B (en
Inventor
于慧敏
王苗苗
许春梦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsinghua University
Original Assignee
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsinghua University filed Critical Tsinghua University
Priority to CN201910549289.5A priority Critical patent/CN110331121B/en
Publication of CN110331121A publication Critical patent/CN110331121A/en
Application granted granted Critical
Publication of CN110331121B publication Critical patent/CN110331121B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/010853-Isopropylmalate dehydrogenase (1.1.1.85)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/03Acyl groups converted into alkyl on transfer (2.3.3)
    • C12Y203/030132-Isopropylmalate synthase (2.3.3.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y206/00Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01Transaminases (2.6.1)
    • C12Y206/01042Branched-chain-amino-acid transaminase (2.6.1.42)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/01Hydro-lyases (4.2.1)
    • C12Y402/010333-Isopropylmalate dehydratase (4.2.1.33)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a kind of recombinant bacterium for the high yield lipopeptid for belonging to gene engineering technology field and its application, the recombinant bacterium of the high yield lipopeptid is that the 2-Isopropylmalate synthase genetic transformation in leucine route of synthesis is built-up to original strain.The recombinant bacterium of further overexpression part leucine synthesis path (2-Isopropylmalate synthase, 3-Isopropylmalate dehydrogenase, 3-Isopropylmalate dehydratase and branched-chain amino acid transaminase) of the invention is compared with starting strain, Surfactin yield highest improves 55.6%, it can be used for the production of Lipopeptide Biosurfactants, with good prospects for commercial application, lipopeptid yield average out to 13-16g/L in fermentation liquid obtained by shake flask fermentation.

Description

A kind of recombinant bacterium of high yield lipopeptid and its application
Technical field
The invention belongs to gene engineering technology fields, and in particular to a kind of recombinant bacterium of high yield lipopeptid and its application.
Background technique
Lipopeptid (lipopeptide) type biological surfactant is a kind of by hydrophilic cyclic oligopeptides and hydrophobic fatty acid The amphiprotic substance that chain is formed by connecting with lactone bond, mainly by Microbe synthesis such as bacillus, streptomycetes.Due to composition lipopeptid Amino acid composition is different from cyclic mode in peptide ring, and bacillus lipopeptid can be divided into Surfactin, fragrant mustard element, iturin Deng wherein there is good surface-active, biological degradability in the Surfactin that air liquid interface forms unique " saddle " conformation And antibacterial activity, all have broad application prospects in fields such as oil exploitation, biological control, medicine and daily use chemicals.But due to gemma Bacillus fermentation production Surfactin low yield limits the industrialized production and application of Surfactin.
Currently, the method for improving microorganism lipopeptid fermentation level includes training systern, mutation breeding, strengthening surface work Property element transdermal delivery, strengthening surface active extract synthesis expression of enzymes, strengthen fatty acid precursor supply etc..Patent document (CN 101892176A, CN 101775427A, WO 2002026961A) etc. by fermentation of bacillus subtilis produce surface-active Culture medium and condition of culture optimize in plain fermentation process, improve the yield of Surfactin in fermentation liquid.Mutation breeding Aspect, CN101928677A, which is disclosed, handles Streptomyces roseosporus by ultraviolet mutagenesis, and US05227294, which is disclosed, uses nitroso First handles bacillus subtilis for urethane, and the microorganism in above-mentioned document is after mutagenic treatment, and Surfactin synthetic quantity is all There is increase.Genetic engineering transformation aspect, Chinese patent literature CN103898038A are disclosed by strengthening lipopeptid from intracellular to born of the same parents The transmembrane protein YcxA of outer transport, the Surfactin output increased 97% of fermentation of bacillus subtilis production.Chinese patent Document CN1554747A discloses in bacillus subtilis expression comA gene, lipopeptid output increased 50%.In addition, withered grass Fatty acid and amino acid catalyze and synthesize Surfactin, Chinese patent under the action of Surfactin synzyme in bacillus Document CN105400784A is by being substituted for inducible strong promoter Pg3, surface-active for lipopeptid synthase gene cluster promoter Plain output increased 17.7 times.Chinese patent literature CN109097315A is by being overexpressed biology in branched chain fatty acid route of synthesis Plain carboxylase YngH, Surfactin output increased 47%.(Qun Wu,Yan Zhi,Yan Xu,Systematically engineering the biosynthesis of a green biosurfactant surfactin by Bacillus [J] .Metabolic of subtilis 168 Engineering, 2019,52:87-97) it discloses and strengthens intracellular Branched fatty Acid synthesizes the supply that precursor fatty acid is improved in whole path, thus 20.8 times of Surfactin output increased.It is living about surface Property element synthesis another kind of main producers amino acid, (Coutte F, Niehren J, Dhali D, et al.Modeling leucine's metabolic pathway and knockout prediction improving the production of surfactin,a biosurfactant from Bacillus subtilis[J].Biotechnology Journal, 2015,10 (8SI): 1216-1234) disclose in culture medium add leucine can make 3 times of Surfactin output increased, explanation Improving leucine content is the available strategy for improving Surfactin yield.But (Qun Wu, Yan Zhi, Yan Xu, Systematically engineering the biosynthesis of a green biosurfactant Surfactin by Bacillus subtilis 168 [J] .Metabolic Engineering, 2019,52:87-97) Acetolactate synthase AlsS, the keto-alcohol acid being overexpressed in leucine route of synthesis in the host strain of production Surfactin restore different Structure enzyme IlvC, dihydroxylated acid dehydratase IlvD, 2-Isopropylmalate synthase LeuA, 3-Isopropylmalate dehydrogenase LeuB and 3-Isopropylmalate dehydratase LeuCD, Surfactin yield are not improved.Have about leucine synthesis in cell is strengthened Effect improves Surfactin production quantifier elimination and has not been reported.
Summary of the invention
The shortcomings that in order to overcome in the prior art, the purpose of the present invention is to provide a kind of recombinations of efficient production lipopeptid The yield of lipopeptid can be improved in bacterium.
The recombinant bacterium is by the 2-Isopropylmalate synthase genetic transformation in leucine route of synthesis to original bacteria Strain is built-up.
Selectable in above-mentioned recombinant bacterium, it is different that the recombinant bacterium has also been transferred to 3-Isopropylmalate dehydrogenase gene, 3- One or more in propyl malic acid dehydrase gene and branched-chain amino acid aminotransferase gene.
In above-mentioned recombinant bacterium, the 3-Isopropylmalate dehydrogenase, 3-Isopropylmalate dehydratase and branched-amino Sour transaminase biotin carboxylase is respectively LeuB, LeuCD and IlvK albumen or its mutant with the same function,
In above-mentioned recombinant bacterium, it is preferred that the amino acid sequence of the LeuB albumen is described as shown in SEQ ID NO.2 The amino acid sequence of LeuC albumen is as shown in SEQ ID NO.3, the amino acid sequence of the LeuD albumen such as SEQ ID NO.4 institute Show, the amino acid sequence of the IlvK albumen is as shown in SEQ ID NO.5.
In above-mentioned recombinant bacterium, the 2-Isopropylmalate synthase is LeuA albumen or its mutation with the same function Body, it is preferred that the amino acid sequence of the LeuA albumen is as shown in SEQ ID NO.1.
In above-mentioned recombinant bacterium, the original strain be with produce lipopeptid ability wild mushroom and its mutagenic fungi, mutant strain or Strain is transformed in genetic engineering.
In above-mentioned recombinant bacterium, the original strain is bacillus subtilis, Bacillus cercus or pseudomonad.
Selectable in above-mentioned recombinant bacterium, the original strain is bacillus subtilis Bacillus subtilis THY-7。
The bacillus subtilis Bacillus subtilis THY-7 is preserved in the micro- life of China on March 11st, 2014 Object culture presevation administration committee common micro-organisms center, preservation registration number are CGMCC No.8906, and in Chinese patent literature It is disclosed in CN 105400784A.
Selectable in above-mentioned recombinant bacterium, the original strain is bacillus subtilis Bacillus subtilis THY-7/Pg3-srfA。
The bacillus subtilis Bacillus subtilis THY-7/Pg3-srfA, refers in bacillus subtilis Inducible strong promoter Pg3 is added in Bacillus subtilis THY-7, closes strong promoter Pg3 control Surfactin At the expression of enzyme srfA.About inducible strong promoter Pg3, bacillus subtilis Bacillus subtilis THY-7/Pg3- SrfA and its specific preparation method have disclosure in Chinese patent literature CN 105400784A.
In above-mentioned recombinant bacterium, LeuA, LeuB, LeuC and LeuD albumen is controlled by strong promoter, the IlvK albumen It is controlled by former constitutive promoter.
The purpose of the present invention also provides application of the above-mentioned recombinant bacterium in production lipopeptid.
In above-mentioned application, the Lipopeptide Biosurfactants are Surfactin.
A kind of preparation method of above-mentioned recombinant bacterium, includes the following steps:
Amplification obtains 2-Isopropylmalate synthase, 3-Isopropylmalate dehydrogenase, 3-Isopropylmalate dehydratase Gene cluster leuABCD and branched-chain amino acid transaminase biotin carboxylase IlvK with itself constitutive promoter, will LeuABCD and IlvK gene order is inserted into shuttle plasmid, constructs expression plasmid;
Expression plasmid is imported into original strain, constructs recombinant bacterium.
Further, method particularly includes:
1, using upstream and downstream primer, polymerase chain reaction is carried out by template of Bacillus subtilis genes group, amplification is simultaneously Obtain leuABCD gene, it is preferred that its nucleic acid sequence is as shown in SEQ ID NO.6.Likewise, ilvK gene is expanded and obtains, Preferably, nucleic acid sequence is as shown in SEQ ID NO.7.
2, leuABCD and ilvK gene and shuttle plasmid are subjected to double digestion respectively, using ligase by two kinds of digestions Product is attached, and obtains connection product.
3, connection product is converted into E. coli TOP10 competent cell, carries out resistance screening positive colony, Obtain the expression plasmid pJMP-leuABCD-ilvK containing leuABCD and ilvK gene order.
4, expression plasmid pJMP-leuABCD-ilvK is transferred in starting strain, obtaining conversion has pJMP-leuABCD- The genetic engineering bacterium of ilvK plasmid.
In the preparation method of said gene engineering bacteria, the construction method of the shuttle plasmid pJMP is in Chinese patent literature It is had disclosed in CN109097315A.
A kind of preparation method of above-mentioned recombinant bacterium, optionally, specific method includes the following:
1, using leuABCD-F and leuABCD-R as upstream and downstream primer, gathered using Bacillus subtilis genes group as template Polymerase chain reaction, expands and obtains leuABCD gene order, nucleic acid sequence is as shown in SEQ ID NO.6;With ilvK-F and IlvK-R is upstream and downstream primer, carries out polymerase chain reaction by template of Bacillus subtilis genes group, expands and obtain IlvK gene order, nucleic acid sequence is as shown in SEQ ID NO.7;
2, leuABCD gene is subjected to Xba I and Mlu I double digestion, ilvK gene is subjected to the bis- enzymes of Mlu I and Nco I It cuts, shuttle plasmid is subjected to Xba I and Nco I double digestion, digestion products is purified, is produced three kinds of digestions using T4 DNA ligase Object is attached, and obtains connection product.
3, connection product is converted into E. coli TOP10 competent cell, the LB for being coated on kanamycins is flat Plate is inverted in 37 DEG C of incubators and is incubated overnight.The resistance clone to grow on picking plate is cultivated, and is extracted plasmid and is carried out Digestion and sequence verification obtain the expression plasmid pJMP-leuABCD-ilvK containing correct leuABCD-ilvK gene order.
4, expression plasmid pJMP-leuABCD-ilvK is transferred to bacillus subtilis B.subtilis using electrotransformation method In THY-7/Pg3-srfA (CN 105400784A), it is coated on the LB plate containing chloramphenicol and kanamycins, picking resistance Clone is cultivated, and PCR verifying is carried out, and obtains the genetic engineering bacterium that conversion has pJMP-leuABCD-ilvK plasmid B.subtilis THY-7/Pg3-srfA(leuABCD-ilvK)。
Preferably, Bacillus subtilis genes group described in step 1 can choose bacillus subtilis 1012wt (MoBiTec company), bacillus subtilis THY-7 (CN 105400784A), THY-8 (chemical industry progress, 2013,32:2952- 2956)、THY-15(Journal of industrial microbiology&biotechnology.2015,42(8): 1139-1147) or carry leuABCD and ilvK gene other Bacillus strains.
Preferably, the preferred pJMP of shuttle plasmid described in step 2, construction method is in Chinese patent literature CN109097315A In have disclosed.
The purpose of the present invention lies also in offer said gene engineering bacteria and is preparing the application in lipopeptid.
Optionally, lipopeptid is produced using above-mentioned recombinant bacterium, steps are as follows:
Recombinant bacterium is accessed in culture medium, expands culture, obtains genetic engineering bacterium bacterium solution;
In the engineering bacteria bacterium solution access fermentation medium for obtaining step (1) according to 1-20% percent by volume, sent out Ferment culture obtains the fermentation liquid containing lipopeptid.
In the above method, the method for expanding culture are as follows: in 35-40 DEG C, the condition that shaking speed is 150-200rpm Lower culture 10-20h.
In the above method, the method for the fermented and cultured be 35-40 DEG C, shaking speed be 150-200rpm under conditions of Continue to cultivate 40-60h after 0.5-1.5mM IPTG inducer is added when cultivating 1.5-4h.
In the above method, the composition of the fermentation medium are as follows: carbohydrate 30-100g/L, inorganic nitrogen-sourced 10-50g/L, it is organic Nitrogen source 0.5-3g/L, KH2PO4 0.1-1g/L,Na2HPO4·12H2O 0.5-0.3g/L,CaCl2 0.002-0.01g/L, MnSO4·H2O 0.002-0.01g/L,FeSO4·7H2O 0.002-0.01g/L,pH 6.5-7.5。
The advantages of the present invention:
The present invention constructs recombinant bacterium using technique for gene engineering, expands and expresses in producing lipopeptid B. subtilis cell 2-Isopropylmalate synthase LeuA, 3-Isopropylmalate dehydrogenase LeuB, 3- isopropyl apple in leucine route of synthesis Tartaric acid dehydratase LeuCD and branched-chain amino acid transaminase IlvK, enhances the synthesis of leucine in Surfactin molecular structure, To significantly improve the yield of lipopeptid.Gained of the invention is overexpressed the recombinant bacterium and starting strain of part leucine synthesis path It compares, Surfactin yield highest improves 55.6%, can be used for the production of Lipopeptide Biosurfactants, has good Prospects for commercial application, lipopeptid yield average out to 13-16g/L in fermentation liquid obtained by shake flask fermentation.
Detailed description of the invention
Fig. 1 is the schematic diagram for gene overexpression plasmid pJMP.
Fig. 2 is the PCR proof diagram of the overexpression plasmid pJMP-leuABCD-ilvK containing leu ABCD-ilvK gene string: Swimming lane 1 is DNA molecular amount standard, and swimming lane 2 is for plasmid using primer ilvK-F and ilv-R progress PCR amplification as a result, available The band of 1.3kb.
Fig. 3 is to carry 2-Isopropylmalate synthase LeuA, 3-Isopropylmalate dehydrogenase LeuB, 3- isopropylmalate The B. subtilis-E. coli shuttle plasmid pJMP- of sour dehydratase LeuCD and branched-chain amino acid transaminase IlvK gene The schematic diagram of leuABCD-ilvK.
Fig. 4 is to be overexpressed 2-Isopropylmalate synthase LeuA, 3-Isopropylmalate dehydrogenase LeuB, 3- isopropyl apple The genetic engineering bacterium B.subtilisTHY-7/Pg3-srfA of tartaric acid dehydratase LeuCD and branched-chain amino acid transaminase IlvK (leuABCD-ilvK) PCR proof diagram: swimming lane 1 is THY-7/Pg3-srfA (pJMP-yngH) with primer ilvK-F and general Primer pJMP-R carry out PCR amplification as a result, the band of 1.5kb can be obtained.Swimming lane 2 is DNA molecular amount standard.
Fig. 5 is original strain THY-7/Pg3-srfA and genetic engineering bacterium THY-7/Pg3-srfA (leuABCD-ilvK) The concentration of Surfactin in tunning.
Specific embodiment
The present invention will be further explained below with reference to the attached drawings and specific examples.Such as not specified, institute in embodiment Biochemical reagents are commercial reagent, and technological means used in embodiment is the conventional hand in those skilled in the art's book Section.
In leucine route of synthesis: glucose generates pyruvic acid by glycolytic pathway, and pyruvic acid is leucine synthesis Precursor.During pyruvic acid generates α -one base isovaleric acid, the rate-limiting step that acetolactic acid is the process is synthesized by pyruvic acid. The enzyme for being catalyzed the step is Acetohydroxyacid synthase, is encoded by gene ilvHB and gene alsS.In α -one base isovaleric acid and second Acyl CoA synthesize L-Leu process, rate-limiting step be by α-isopropylmalate synthetase catalyzed synthesizing alpha-isopropylmolic acid, The gene for encoding the enzyme is leuA.
This 3 related gene discoveries: surface-active when being overexpressed alsS and ilvHB are expressed in inventor's previous experiments respectively The synthesis of element significantly reduces, and Surfactin yield is promoted when being overexpressed leuA, and lipopeptid yield is 11.58g/L, improves 13.5%, when being overexpressed leuAB, lipopeptid yield is not promoted further.
Embodiment 1 carries the plasmid construction of gene leuABCD and ilvK in leucine route of synthesis
Picking bacillus subtilis B.subtilis THY-7 single colonie, is inoculated in LB liquid medium, is placed in 37 DEG C, be incubated overnight in the shaking table of 200rpm, collect thallus under 12000rpm, 5min centrifugal condition, use the thin of Omega company Bacterium genome extraction kit extracts THY-7 genome.Using obtained genome as template, upstream primer leuABCD-F is used (sequence is as shown in SEQ ID NO.8) and downstream primer leuABCD-R (sequence is as shown in SEQ ID NO.9) carry out PCR amplification Obtain leuABCD segment.Use upstream primer ilvK-F (sequence is as shown in SEQ ID NO.10) and downstream primer ilvK-R (sequence Column as shown in SEQ ID NO.11) progress PCR amplification obtain ilvK fragment primer by Bo Shang biotechnology (Shanghai) Co., Ltd. Synthesis, dissolved with sterile water and be diluted to 10 μM it is spare.Polymerase, buffer used in PCR amplification and restriction enzyme are purchased from TaKaRa company.Pcr amplification reaction system are as follows:
Thermal cycle conditions are
Amplification purification obtains bacillus subtilis leuABCD gene segment, and sequence is as shown in SEQ ID NO.6, amplification Purifying obtains bacillus subtilis ilvK gene segment, and sequence is as shown in SEQ ID NO.7.LeuABCD gene is subjected to Xba IlvK gene is carried out Mlu I and Nco I double digestion by I and Mlu I double digestion, and it is bis- that shuttle plasmid is carried out Xba I and Nco I Digestion is purified with the DNA purification kit of Omega company after 27-33 DEG C of digestion 1-3h, and T4 DNA ligase is then used (NEB company) connects overnight under the conditions of 16-22 DEG C.Connection product converts E. coli TOP10 competent cell (TianGen company) is coated on the LB plate containing kanamycins, is inverted in 37 DEG C of incubators and is incubated overnight.On picking plate Longer resistance clone carries out bacterium colony PCR, is to draw with ilvK-F and Plasmid Primer ilvK-R using the bacterium colony of picking as template Object, amplifying about 1.3Kb band (as shown in Figure 2) is positive colony, and picking positive colony culture is extracted plasmid and is sequenced and tests Card, obtains the expression plasmid pJMP-leuABCD-ilvK containing leuABCD and ilvK gene, and wherein Fig. 1 is showing for plasmid pJMP It is intended to.
The genetic engineering bacterium B.subtilis THY-7/Pg3-srfA of the overexpression leucine route of synthesis of embodiment 2 (leuABCD-ilvK) building
By the carrying 2-Isopropylmalate synthase LeuA constructed in embodiment 1,3-Isopropylmalate dehydrogenase LeuB, The B. subtilis-E. coli shuttle matter of 3-Isopropylmalate dehydratase LeuCD and branched-chain amino acid transaminase IlvK Grain pJMP-leuABCD-ilvK can be obtained with the competent cell of electroporation conversion bacillus subtilis THY-7/Pg3-srfA To the genetic engineering bacterium THY-7/Pg3-srfA (leuABCD-ilvK) for being overexpressed leucine synthesis path portion gene.Wherein, The preparation of bacillus subtilis THY-7/Pg3-srfA competent cell and electrotransformation use Chinese patent literature Method in CN105400784A.
It takes 100uL bacterium solution to be coated on the LB solid medium of the g/mL kanamycins of μ containing 10-30 after recovery, is inverted in 37 It is incubated overnight in DEG C incubator, picking single colonie, carries out PCR verifying using upstream and downstream primer ilvK-F and pJMP-R, it is amplifiable About 1.5kb band out, verification result are overexpressed 2-Isopropylmalate synthase LeuA, 3- isopropyl apple as shown in figure 4, obtaining The genetic engineering bacterium of tartaric acid dehydrogenase LeuB, 3-Isopropylmalate dehydratase LeuCD and branched-chain amino acid transaminase IlvK THY-7/Pg3-srfA(leuABCD-ilvK).The Plasmid Primer pJMP-R sequence is as shown in SEQ ID NO.12.
Embodiment 3 produces lipopeptid class surface-active using genetic engineering bacterium THY-7/Pg3-srfA (leuABCD-ilvK) Agent-Surfactin
By the obtained overexpression 2-Isopropylmalate synthase LeuA of embodiment 2,3-Isopropylmalate dehydrogenase The genetic engineering bacterium THY-7/Pg3- of LeuB, 3-Isopropylmalate dehydratase LeuCD and branched-chain amino acid transaminase IlvK SrfA (leuABCD-ilvK) is inoculated in LB liquid medium (containing chloramphenicol and kanamycins), and 37 DEG C, under the conditions of 200rpm 16h is cultivated, with 5% ratio access equipped in the shaking flask of 100mL fermentation medium, 37 DEG C, cultivate 2-6h under the conditions of 200rpm When IPTG is added, continue to cultivate to 2-3d to get to the fermentation liquid containing lipopeptid.
Surfactin detection is used in the intelligent quick method for waiting (Chinese patent CN 105400784A) in fermentation liquid.Gene Engineering bacteria THY-7/Pg3-srfA (leuABCD-ilvK) and Surfactin in starting strain THY-7/Pg3-srfA fermentation liquid The statistical result of concentration is as shown in Figure 5: THY-7/Pg3-srfA (leuABCD-ilvK) Surfactin yield reaches as high as 15.8g/L goes out bacterium germination (10.2g/L) than THY-7/Pg3-srfA and improves 54.9%.5L fermentation tank culture THY-7/Pg3- SrfA (leuABCD-ilvK), Surfactin yield are up to 19g/L.
The above embodiments are only used to illustrate the technical solution of the present invention., rather than its limitations;Although referring to aforementioned each reality Applying example, invention is explained in detail, those skilled in the art should understand that: it still can be to aforementioned each Technical solution documented by embodiment is modified, or equivalent substitution of some or all of the technical features;And These are modified or replaceed, the range for technical solution of various embodiments of the present invention that it does not separate the essence of the corresponding technical solution.
Sequence table
<110>Tsinghua University
<120>a kind of recombinant bacterium of high yield lipopeptid and its application
<130> 0
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 518
<212> PRT
<213> Bacillus subtilis
<400> 1
Met Arg Lys Ile Asn Phe Phe Asp Thr Thr Leu Arg Asp Gly Glu Gln
1 5 10 15
Ser Pro Gly Val Asn Leu Asn Thr Gln Glu Lys Leu Ala Ile Ala Lys
20 25 30
Gln Leu Glu Arg Leu Gly Ala Asp Ile Ile Glu Ala Gly Phe Pro Ala
35 40 45
Ser Ser Arg Gly Asp Phe Leu Ala Val Gln Glu Ile Ala Arg Thr Ile
50 55 60
Lys Asn Cys Ser Val Thr Gly Leu Ala Arg Cys Val Lys Gly Asp Ile
65 70 75 80
Asp Ala Ala Trp Glu Ala Leu Lys Glu Gly Ser His Pro Arg Ile His
85 90 95
Val Phe Ile Ala Thr Ser Asp Ile His Leu Lys His Lys Leu Lys Met
100 105 110
Thr Arg Glu Gln Val Ile Glu Arg Ala Val Glu Met Val Lys Tyr Ala
115 120 125
Lys Glu Arg Phe Pro Ile Val Gln Trp Ser Ala Glu Asp Ala Cys Arg
130 135 140
Thr Glu Leu Pro Phe Leu Ala Glu Ile Val Glu Lys Val Ile Asp Ala
145 150 155 160
Gly Ala Ser Val Ile Asn Leu Pro Asp Thr Val Gly Tyr Leu Ala Pro
165 170 175
Ala Glu Tyr Gly Asn Ile Phe Arg Tyr Met Lys Glu Asn Val Pro Asn
180 185 190
Ile His Lys Ala Lys Leu Ser Ala His Cys His Asp Asp Leu Gly Met
195 200 205
Ala Val Ala Asn Ser Leu Ala Ala Ile Glu Asn Gly Ala Asp Gln Ile
210 215 220
Glu Cys Ala Val Asn Gly Ile Gly Glu Arg Ala Gly Asn Ala Ala Leu
225 230 235 240
Glu Glu Ile Ala Val Ala Leu His Thr Arg Lys Asp Phe Tyr Gln Val
245 250 255
Glu Thr Gly Ile Thr Leu Asn Glu Ile Lys Arg Thr Ser Asp Leu Val
260 265 270
Ser Lys Leu Thr Gly Met Ala Val Pro Arg Asn Lys Ala Val Val Gly
275 280 285
Asp Asn Ala Phe Ala His Glu Ser Gly Ile His Gln Asp Gly Phe Leu
290 295 300
Lys Glu Lys Ser Thr Tyr Glu Ile Ile Ser Pro Glu Leu Val Gly Val
305 310 315 320
Thr Ala Asp Ala Leu Val Leu Gly Lys His Ser Gly Arg His Ala Phe
325 330 335
Lys Asp Arg Leu Thr Ala Leu Gly Phe Gln Phe Asp Ser Glu Glu Ile
340 345 350
Asn Lys Phe Phe Thr Met Phe Lys Glu Leu Thr Glu Lys Lys Lys Glu
355 360 365
Ile Thr Asp Glu Asp Leu Val Ser Leu Ile Leu Glu Glu Lys Val Thr
370 375 380
Asp Arg Lys Ile Gly Tyr Glu Phe Leu Ser Leu Gln Val His Tyr Gly
385 390 395 400
Thr Ser Gln Val Pro Thr Ala Thr Leu Ser Leu Lys Asn Gln Glu Asn
405 410 415
Ala Glu Leu Ile Gln Glu Ala Ala Thr Gly Ala Gly Ser Val Glu Ala
420 425 430
Ile Tyr Asn Thr Leu Glu Arg Cys Ile Asp Lys Asp Val Glu Leu Leu
435 440 445
Asp Tyr Arg Ile Gln Ser Asn Arg Lys Gly Glu Asp Ala Phe Ala Gln
450 455 460
Val Tyr Val Arg Val Leu Val Asn Gly Lys Glu Ser Ala Gly Arg Gly
465 470 475 480
Ile Ala Gln Asp Val Leu Glu Ala Ser Ala Lys Ala Tyr Leu Asn Ala
485 490 495
Val Asn Arg Gln Leu Val Phe Gln Ser Asn Met Ser Gly Leu Lys Asn
500 505 510
His Thr Ala Val Gly Ser
515
<210> 2
<211> 365
<212> PRT
<213> Bacillus subtilis
<400> 2
Leu Lys Lys Arg Ile Ala Leu Leu Pro Gly Asp Gly Ile Gly Pro Glu
1 5 10 15
Val Leu Glu Ser Ala Thr Asp Val Leu Lys Ser Val Ala Glu Arg Phe
20 25 30
Asn His Glu Phe Glu Phe Glu Tyr Gly Leu Ile Gly Gly Ala Ala Ile
35 40 45
Asp Glu His His Asn Pro Leu Pro Glu Lys Thr Val Ala Ala Cys Lys
50 55 60
Asn Ala Asp Ala Ile Leu Leu Gly Ala Val Gly Gly Pro Lys Trp Asp
65 70 75 80
Gln Asn Pro Ser Glu Leu Arg Pro Glu Lys Gly Leu Leu Ser Ile Arg
85 90 95
Lys Gln Leu Asp Leu Phe Ala Asn Leu Arg Pro Val Lys Val Phe Glu
100 105 110
Ser Leu Ser Asp Ala Ser Pro Leu Lys Lys Glu Tyr Ile Asp Asn Val
115 120 125
Asp Phe Val Ile Val Arg Glu Leu Thr Gly Gly Leu Tyr Phe Gly Gln
130 135 140
Pro Ser Lys Arg Tyr Val Asn Thr Glu Gly Glu Gln Glu Ala Val Asp
145 150 155 160
Thr Leu Phe Tyr Lys Arg Thr Glu Ile Glu Arg Val Ile Arg Glu Gly
165 170 175
Phe Lys Met Ala Ala Ala Arg Lys Gly Lys Val Thr Ser Val Asp Lys
180 185 190
Ala Asn Val Leu Glu Ser Ser Arg Leu Trp Arg Glu Val Ala Glu Asp
195 200 205
Val Ala Lys Glu Phe Pro Asp Val Lys Leu Glu His Met Leu Val Asp
210 215 220
Asn Ala Ala Met Gln Leu Ile Tyr Ala Pro Asn Gln Phe Asp Val Val
225 230 235 240
Val Thr Glu Asn Met Phe Gly Asp Ile Leu Ser Asp Glu Ala Ser Met
245 250 255
Leu Thr Gly Ser Leu Gly Met Leu Pro Ser Ala Ser Leu Ser Ser Ser
260 265 270
Gly Leu His Leu Phe Glu Pro Val His Gly Ser Ala Pro Asp Ile Ala
275 280 285
Gly Lys Gly Met Ala Asn Pro Phe Ala Ala Ile Leu Ser Ala Ala Met
290 295 300
Leu Leu Arg Thr Ser Phe Gly Leu Glu Glu Glu Ala Lys Ala Val Glu
305 310 315 320
Asp Ala Val Asn Lys Val Leu Ala Ser Gly Lys Arg Thr Lys Asp Leu
325 330 335
Ala Arg Gly Glu Glu Phe Ser Ser Thr Gln Ala Ile Thr Glu Glu Val
340 345 350
Lys Ala Ala Ile Met Ser Glu Asn Thr Met Ser Asn Val
355 360 365
<210> 3
<211> 472
<212> PRT
<213> Bacillus subtilis
<400> 3
Met Met Pro Arg Thr Ile Ile Glu Lys Ile Trp Asp Gln His Ile Val
1 5 10 15
Lys His Gly Glu Gly Lys Pro Asp Leu Leu Tyr Ile Asp Leu His Leu
20 25 30
Ile His Glu Val Thr Ser Pro Gln Ala Phe Glu Gly Leu Arg Gln Lys
35 40 45
Gly Arg Lys Val Arg Arg Pro Gln Asn Thr Phe Ala Thr Met Asp His
50 55 60
Asn Ile Pro Thr Val Asn Arg Phe Glu Ile Lys Asp Glu Val Ala Lys
65 70 75 80
Arg Gln Val Thr Ala Leu Glu Arg Asn Cys Glu Glu Phe Gly Val Arg
85 90 95
Leu Ala Asp Leu His Ser Val Asp Gln Gly Ile Val His Val Val Gly
100 105 110
Pro Glu Leu Gly Leu Thr Leu Pro Gly Lys Thr Ile Val Cys Gly Asp
115 120 125
Ser His Thr Ser Thr His Gly Ala Phe Gly Ala Leu Ala Phe Gly Ile
130 135 140
Gly Thr Ser Glu Val Glu His Val Leu Ser Thr Gln Thr Leu Trp Gln
145 150 155 160
Gln Arg Pro Lys Thr Leu Glu Val Arg Val Asp Gly Thr Leu Gln Lys
165 170 175
Gly Val Thr Ala Lys Asp Val Ile Leu Ala Val Ile Gly Lys Tyr Gly
180 185 190
Val Lys Phe Gly Thr Gly Tyr Val Ile Glu Tyr Thr Gly Glu Val Phe
195 200 205
Arg Asn Met Thr Met Asp Glu Arg Met Thr Val Cys Asn Met Ser Ile
210 215 220
Glu Ala Gly Ala Arg Ala Gly Leu Ile Ala Pro Asp Glu Val Thr Phe
225 230 235 240
Glu Tyr Cys Lys Asn Arg Lys Tyr Thr Pro Lys Gly Glu Glu Phe Asp
245 250 255
Lys Ala Val Glu Glu Trp Lys Ala Leu Arg Thr Asp Pro Gly Ala Val
260 265 270
Tyr Asp Lys Ser Ile Val Leu Asp Gly Asn Lys Ile Ser Pro Met Val
275 280 285
Thr Trp Gly Ile Asn Pro Gly Met Val Leu Pro Val Asp Ser Glu Val
290 295 300
Pro Ala Pro Glu Ser Phe Ser Ala Glu Asp Asp Lys Lys Glu Ala Ile
305 310 315 320
Arg Ala Tyr Glu Tyr Met Gly Leu Thr Pro His Gln Lys Ile Glu Asp
325 330 335
Ile Lys Val Glu His Val Phe Ile Gly Ser Cys Thr Asn Ser Arg Met
340 345 350
Thr Asp Leu Arg Gln Ala Ala Asp Met Ile Lys Gly Lys Lys Val Ala
355 360 365
Asp Ser Val Arg Ala Ile Val Val Pro Gly Ser Gln Arg Val Lys Leu
370 375 380
Gln Ala Glu Lys Glu Gly Leu Asp Gln Ile Phe Leu Glu Ala Gly Phe
385 390 395 400
Glu Trp Arg Glu Ser Gly Cys Ser Met Cys Leu Ser Met Asn Asn Asp
405 410 415
Val Val Pro Glu Gly Glu Arg Cys Ala Ser Thr Ser Asn Arg Asn Phe
420 425 430
Glu Gly Arg Gln Gly Lys Gly Ala Arg Thr His Leu Val Ser Pro Ala
435 440 445
Met Ala Ala Met Ala Ala Ile His Gly His Phe Val Asp Val Arg Lys
450 455 460
Phe Tyr Gln Glu Lys Thr Val Val
465 470
<210> 4
<211> 199
<212> PRT
<213> Bacillus subtilis
<400> 4
Met Glu Pro Leu Lys Ser His Thr Gly Lys Ala Ala Val Leu Asn Arg
1 5 10 15
Ile Asn Val Asp Thr Asp Gln Ile Ile Pro Lys Gln Phe Leu Lys Arg
20 25 30
Ile Glu Arg Thr Gly Tyr Gly Arg Phe Ala Phe Phe Asp Trp Arg Tyr
35 40 45
Asp Ala Asn Gly Glu Pro Asn Pro Glu Phe Glu Leu Asn Gln Pro Val
50 55 60
Tyr Gln Gly Ala Ser Ile Leu Ile Ala Gly Glu Asn Phe Gly Cys Gly
65 70 75 80
Ser Ser Arg Glu His Ala Pro Trp Ala Leu Asp Asp Tyr Gly Phe Lys
85 90 95
Ile Ile Ile Ala Pro Ser Phe Ala Asp Ile Phe His Gln Asn Cys Phe
100 105 110
Lys Asn Gly Met Leu Pro Ile Arg Met Pro Tyr Asp Asn Trp Lys Gln
115 120 125
Leu Val Gly Gln Tyr Glu Asn Lys Ser Leu Gln Met Thr Val Asp Leu
130 135 140
Glu Asn Gln Leu Ile His Asp Ser Glu Gly Asn Gln Ile Ser Phe Glu
145 150 155 160
Val Asp Pro His Trp Lys Glu Met Leu Ile Asn Gly Tyr Asp Glu Ile
165 170 175
Ser Leu Thr Leu Leu Leu Glu Asp Glu Ile Lys His Phe Glu Ser Gln
180 185 190
Arg Ser Ser Trp Leu Gln Ala
195
<210> 5
<211> 363
<212> PRT
<213> Bacillus subtilis
<400> 5
Met Thr Lys Gln Thr Ile Arg Val Glu Leu Thr Ser Thr Lys Lys Pro
1 5 10 15
Lys Pro Asp Pro Asn Gln Leu Ser Phe Gly Arg Val Phe Thr Asp His
20 25 30
Met Phe Val Met Asp Tyr Ala Ala Asp Lys Gly Trp Tyr Asp Pro Arg
35 40 45
Ile Ile Pro Tyr Gln Pro Leu Ser Met Asp Pro Ala Ala Met Val Tyr
50 55 60
His Tyr Gly Gln Thr Val Phe Glu Gly Leu Lys Ala Tyr Val Ser Glu
65 70 75 80
Asp Asp His Val Leu Leu Phe Arg Pro Glu Lys Asn Met Glu Arg Leu
85 90 95
Asn Gln Ser Asn Asp Arg Leu Cys Ile Pro Gln Ile Asp Glu Glu Gln
100 105 110
Val Leu Glu Gly Leu Lys Gln Leu Val Ala Ile Asp Lys Asp Trp Ile
115 120 125
Pro Asn Ala Glu Gly Thr Ser Leu Tyr Ile Arg Pro Phe Ile Ile Ala
130 135 140
Thr Glu Pro Phe Leu Gly Val Ala Ala Ser His Thr Tyr Lys Leu Leu
145 150 155 160
Ile Ile Leu Ser Pro Val Gly Ser Tyr Tyr Lys Glu Gly Ile Lys Pro
165 170 175
Val Lys Ile Ala Val Glu Ser Glu Phe Val Arg Ala Val Lys Gly Gly
180 185 190
Thr Gly Asn Ala Lys Thr Ala Gly Asn Tyr Ala Ser Ser Leu Lys Ala
195 200 205
Gln Gln Val Ala Glu Glu Lys Gly Phe Ser Gln Val Leu Trp Leu Asp
210 215 220
Gly Ile Glu Lys Lys Tyr Ile Glu Glu Val Gly Ser Met Asn Ile Phe
225 230 235 240
Phe Lys Ile Asn Gly Glu Ile Val Thr Pro Met Leu Asn Gly Ser Ile
245 250 255
Leu Glu Gly Ile Thr Arg Asn Ser Val Ile Ala Leu Leu Lys His Trp
260 265 270
Gly Leu Gln Val Ser Glu Arg Lys Ile Ala Ile Asp Glu Val Ile Gln
275 280 285
Ala His Lys Asp Gly Ile Leu Glu Glu Ala Phe Gly Thr Gly Thr Ala
290 295 300
Ala Val Ile Ser Pro Val Gly Glu Leu Ile Trp Gln Asp Glu Thr Leu
305 310 315 320
Ser Ile Asn Asn Gly Glu Thr Gly Glu Ile Ala Lys Lys Leu Tyr Asp
325 330 335
Thr Ile Thr Gly Ile Gln Lys Gly Ala Val Ala Asp Glu Phe Gly Trp
340 345 350
Thr Thr Glu Val Ala Ala Leu Thr Glu Ser Lys
355 360
<210> 6
<211> 4755
<212> DNA
<213> Bacillus subtilis
<400> 6
atgcgcaaaa ttaatttttt cgatacgacg cttcgtgatg gtgaacagtc ccctggagtg 60
aacttgaata cacaggagaa acttgccata gctaagcagc tcgaaagact cggggcagat 120
atcattgaag cgggatttcc cgcttcgtcc cgaggtgact ttttagctgt tcaggaaatc 180
gcaagaacca ttaaaaattg ttcagtaact ggtctggccc gttgtgtaaa aggtgatatt 240
gatgctgctt gggaagcgtt aaaagaaggt tctcacccga gaattcatgt ttttatcgcc 300
acatcggaca ttcatttgaa gcacaagctg aaaatgacac gtgagcaagt cattgaaaga 360
gcggttgaaa tggtgaaata cgcaaaagaa cgttttccga ttgtgcaatg gtcagctgaa 420
gatgcctgcc gcactgaact gccgtttcta gcagaaatcg tcgaaaaagt gattgacgca 480
ggcgccagtg ttatcaatct tccggacact gtcggctacc tggctccggc ggaatacgga 540
aatatcttta gatatatgaa ggaaaacgtt ccgaacattc acaaagcaaa gctttcagcc 600
cactgtcatg atgatttagg aatggcagtc gcaaactctc ttgctgcgat tgaaaatggc 660
gctgatcaaa tcgaatgcgc tgtgaacggg atcggtgaaa gagccggaaa cgcggcatta 720
gaggaaattg ccgtagccct ccataccaga aaagatttct accaagtcga aacaggcatt 780
acactgaacg agattaagag aacaagtgat ttagtaagca aactgacagg catggctgtc 840
ccgcgcaaca aagcggttgt tggagataat gcatttgctc atgaatcagg catccatcag 900
gacggctttt taaaggaaaa atcgacttat gaaattattt caccggagct tgtcggcgta 960
accgcagatg cgcttgtcct aggtaaacat tccggacgcc acgcatttaa agaccggctg 1020
actgctttag gattccaatt tgacagtgaa gagattaata aattctttac gatgttcaaa 1080
gagttgactg agaagaaaaa agaaatcact gatgaggatc ttgtttctct tattttagaa 1140
gaaaaagtaa cagatcgcaa gattgggtat gaatttcttt ctctgcaagt acattacgga 1200
acaagtcagg tccctacggc tactctttcg ttgaaaaatc aagaaaacgc agagcttatt 1260
caggaagctg caactggagc tggaagtgtg gaagcaatct acaatacgct tgagcgctgc 1320
atcgataagg acgtggagct cttagactac cgcattcagt ctaacagaaa aggcgaagat 1380
gcatttgccc aggtgtatgt aagagttttg gtgaacggaa aagaatcagc aggtcggggc 1440
atagcgcaag acgtattaga agcatcagcg aaagcctatt tgaacgcagt caaccgtcaa 1500
ttggttttcc agtcgaatat gagcggattg aaaaaccaca cagctgtcgg atcataaaag 1560
aaaggagaac ggttaacttg aagaaacgta ttgctctatt gcccggagac gggatcggcc 1620
ctgaagtatt agaatcagcg acagacgtac tgaaaagtgt tgccgaacgc tttaaccatg 1680
aatttgaatt tgaatatggc ctgattggag gggcggctat tgatgaacat cataaccccc 1740
tcccggagaa aaccgttgct gcttgtaaaa atgcagacgc gatattgctt ggcgctgtcg 1800
gcggaccgaa atgggatcaa aatccttcgg aactgagacc ggaaaaaggg ctgctcagca 1860
tcagaaaaca gcttgatttg tttgcgaatt tacggcctgt gaaggtattt gaaagccttt 1920
ctgacgcttc gcctttgaaa aaagaatata tagataatgt tgatttcgtt atcgttcgtg 1980
aactcacagg cggcttgtat ttcggccagc cgagcaaacg ctatgtaaac actgaaggtg 2040
agcaggaagc agtagataca ctgttttata agcgaacgga aattgaacga gtgatcagag 2100
agggcttcaa aatggcggca gccagaaaag gcaaagtgac ctctgtagat aaagcgaatg 2160
ttcttgaatc aagccggctg tggcgtgaag tggctgagga cgttgcgaaa gaatttcctg 2220
atgtgaagct tgagcacatg cttgtggata acgcggccat gcagctaatc tatgcaccga 2280
atcaatttga tgtcgttgtg actgaaaata tgttcggtga tattttaagc gatgaagcgt 2340
ccatgcttac aggctcgctc ggaatgctcc cgtcagccag cctatcaagc tctggtcttc 2400
atctgtttga acctgttcat ggctccgcgc ctgatattgc tggtaaaggg atggcaaatc 2460
cgttcgcagc catattgtca gcggcaatgc ttttgaggac atctttcggg cttgaagagg 2520
aagcgaaagc tgtagaagat gcggtaaaca aagtcttggc ttccggaaaa agaacaaaag 2580
acttggcacg gggtgaagag ttcagcagca ctcaggccat tacagaggaa gttaaggcag 2640
caatcatgag tgaaaataca atgtctaatg tgtgacagct tacgttaagc ggtcttagct 2700
ctaggtagag ggaggaaata aaagatgatg cctcgaacaa tcatcgaaaa gatttgggat 2760
cagcatattg taaaacatgg tgagggaaag ccggatcttc tctatattga tttgcacctc 2820
attcatgagg tgacgtctcc tcaggcattt gaaggcttga gacaaaaggg aagaaaggtc 2880
agaagacccc aaaacacatt tgcgacaatg gaccacaaca tcccgactgt caatcgtttt 2940
gagataaagg atgaagttgc gaaacgccag gtaacggcgc ttgaaagaaa ctgtgaggaa 3000
tttggcgtgc gccttgccga tcttcacagc gtggatcaag ggattgtcca tgtcgtcggc 3060
cctgaactgg gcttaacgct tccagggaaa acgattgtgt gcggggacag tcatacatca 3120
acacatggcg ctttcggcgc tcttgcattt ggaatcggga cgagtgaagt cgaacatgtt 3180
ctttccacac agacactttg gcagcagcgt ccaaaaacac ttgaagtgcg cgtagatgga 3240
acgcttcaaa aaggggtaac ggcaaaggat gtcatccttg ctgtcatcgg caaatacggt 3300
gtgaaattcg gcacaggcta cgtcattgaa tacactgggg aagtattcag aaatatgacg 3360
atggatgaac gaatgactgt ttgtaacatg tcaattgaag caggagcaag agcaggtttg 3420
attgcacctg acgaggtgac gtttgaatat tgcaaaaatc gcaagtacac gccaaaaggc 3480
gaagaatttg acaaggccgt agaggaatgg aaggcgctgc gcacagaccc gggcgctgtt 3540
tacgataaat ctatcgtcct tgacggcaac aaaatttccc ctatggtgac atggggcatt 3600
aacccgggaa tggttcttcc tgtcgattct gaagttcctg cgccggaaag cttttctgca 3660
gaagatgata aaaaagaagc gattcgcgct tatgaatata tgggactgac tcctcatcag 3720
aaaattgaag acattaaagt ggagcacgta tttatcggtt cctgcacaaa ttcccgcatg 3780
actgaccttc gccaggctgc tgacatgatc aaggggaaga aggtagctga cagcgtaagg 3840
gccatcgtcg tgcccggatc ccaaagagtg aagcttcagg ctgaaaaaga agggcttgac 3900
caaattttct tggaagctgg atttgaatgg agagagtcag gctgcagcat gtgtttgagt 3960
atgaataatg atgttgttcc tgagggagag cgctgtgcat caacctctaa ccgcaacttc 4020
gagggcagac aaggaaaagg tgcaagaaca catctcgtca gcccggcaat ggctgcgatg 4080
gctgccattc acggacactt cgttgatgtc agaaagtttt atcaggaaaa aacagttgtg 4140
taaggagtgc gcgagatgga acctttgaaa tcacatacgg ggaaagcagc cgtattaaat 4200
cggatcaatg tggatacaga ccagattatt cctaagcaat ttttgaagag gattgaaaga 4260
acaggctacg ggcgttttgc attctttgac tggagatatg atgcgaatgg tgaaccgaac 4320
cctgaatttg aattaaacca gcctgtttat caaggagctt ccattttaat agcaggagaa 4380
aacttcggct gcgggtcatc gcgtgaacat gctccgtggg cacttgatga ttatgggttt 4440
aaaattatca ttgcgccgtc attcgctgat attttccatc agaactgctt taaaaacggc 4500
atgcttccga tccgcatgcc atatgacaat tggaaacagc ttgtcggcca gtatgaaaac 4560
aagtcattgc aaatgactgt tgaccttgaa aatcagctga ttcatgacag tgaaggcaat 4620
caaatttcat ttgaagttga cccgcattgg aaagagatgc tgatcaacgg atatgatgaa 4680
atttcattaa cgctgctgct ggaagatgaa atcaagcatt ttgaatcaca aagaagctct 4740
tggcttcaag cctga 4755
<210> 7
<211> 1247
<212> DNA
<213> Bacillus subtilis
<400> 7
agcgcttata cgcgttttct cctgcttttt tcatatgaat ttcttacaaa tttgagcaaa 60
cctattgcga ttatttgttg aaggtataca atagaatata attattttca aataagtttg 120
ataatataaa caatttaaca gcagggagat tgaccatgac taaacaaaca attcgcgttg 180
aattgacatc aacaaaaaaa ccgaaaccag acccaaatca gctttcgttc ggaagagtgt 240
ttacagacca catgtttgta atggactatg ccgcagataa aggttggtac gatccaagaa 300
tcattcctta tcagccctta tcaatggatc cggccgcaat ggtctatcac tacggccaaa 360
ccgtgtttga agggttaaag gcttacgtgt cagaggatga ccatgttctg cttttcagac 420
cggaaaaaaa tatggaacgc ctgaatcaat caaacgaccg cctctgcatc ccgcaaattg 480
atgaagaaca ggttcttgaa ggcttaaagc agcttgtcgc aattgataaa gactggattc 540
caaatgcgga gggcacgtcc ctatacatcc gtccgttcat catcgcaacc gagcctttcc 600
ttggtgttgc ggcatctcat acgtataagc tcttgatcat tctttctccg gtcggctctt 660
attacaaaga aggcattaag ccggtcaaaa tcgctgttga aagtgaattt gtccgtgcgg 720
taaaaggcgg aacaggaaat gccaaaaccg cagggaacta cgcttcaagc ttaaaagcgc 780
agcaggtcgc cgaagagaaa ggattttccc aagtgctttg gctggacggc attgagaaga 840
aatacatcga agaagttgga agcatgaaca tcttcttcaa aatcaacggt gaaatcgtaa 900
cgccgatgct gaacggaagc atcctggaag gcattacgcg caattcagtc atcgccttgc 960
ttaagcattg gggccttcaa gtttcagaac ggaaaattgc gatcgatgag gtcatccaag 1020
cccataaaga cggcatcctg gaagaagcct tcggaacagg tacagcagct gttatttccc 1080
cagtcggcga gctgatctgg caggatgaaa cactttcgat caacaacggt gaaacaggag 1140
aaatcgcaaa aaaactatat gacacgatta caggcattca aaaaggcgct gtcgcagacg 1200
aattcggatg gacgaccgaa gttgcagcgc tgactgaaag caagtaa 1247
<210> 8
<211> 35
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 8
cactctagaa tgcgcaaaat taattttttc gatac 35
<210> 9
<211> 35
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 9
taacgcgttc aggcttgaag ccaagagctt ctttg 35
<210> 10
<211> 34
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 10
acaacgcgtt ttctcctgct tttttcatat gaat 34
<210> 11
<211> 29
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 11
cacccatggt tacttgcttt cagtcagcg 29
<210> 12
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 12
cagcctttgt tggttctttt 20

Claims (10)

1. a kind of recombinant bacterium of high yield lipopeptid is by the 2-Isopropylmalate synthase genetic transformation in leucine route of synthesis It is built-up to original strain.
2. recombinant bacterium according to claim 1, which is characterized in that it is de- that the recombinant bacterium has also been transferred to 3- isopropylmolic acid One or more in hydrogenase gene, 3-Isopropylmalate dehydratase gene and branched-chain amino acid aminotransferase gene.
3. recombinant bacterium according to claim 2, which is characterized in that the 3-Isopropylmalate dehydrogenase, 3- isopropyl Malic acid dehydratase and branched-chain amino acid transaminase biotin carboxylase is respectively LeuB, LeuCD and IlvK albumen or it has The mutant of identical function, it is preferred that the amino acid sequence of the LeuB albumen is as shown in SEQ ID NO.2, the LeuC egg White amino acid sequence is as shown in SEQ ID NO.3, and the amino acid sequence of the LeuD albumen is as shown in SEQ ID NO.4, institute The amino acid sequence of IlvK albumen is stated as shown in SEQ ID NO.5.
4. recombinant bacterium according to claim 1, which is characterized in that the 2-Isopropylmalate synthase be LeuA albumen or Its mutant with the same function, it is preferred that the amino acid sequence of the LeuA albumen is as shown in SEQ ID NO.1.
5. recombinant bacterium according to claim 1-4, which is characterized in that the original strain is with production lipopeptid energy Strain is transformed in the wild mushroom and its mutagenic fungi of power, mutant strain or genetic engineering.
6. recombinant bacterium according to claim 5, which is characterized in that the original strain is bacillus subtilis, wax-like bud Spore bacillus or pseudomonad.
7. recombinant bacterium according to claim 6, which is characterized in that the original strain is bacillus subtilis Bacillus subtilis THY-7。
8. recombinant bacterium according to claim 7, which is characterized in that the original strain is bacillus subtilis Bacillus subtilis THY-7/Pg3-srfA。
9. recombinant bacterium according to claim 8, which is characterized in that LeuA, LeuB, LeuC and LeuD albumen is opened by force Mover control, the IlvK albumen are controlled by former constitutive promoter.
10. application of the described in any item recombinant bacteriums of claim 1-9 in production lipopeptid.
CN201910549289.5A 2019-06-24 2019-06-24 Recombinant bacterium for high-yield lipopeptide and application thereof Active CN110331121B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910549289.5A CN110331121B (en) 2019-06-24 2019-06-24 Recombinant bacterium for high-yield lipopeptide and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910549289.5A CN110331121B (en) 2019-06-24 2019-06-24 Recombinant bacterium for high-yield lipopeptide and application thereof

Publications (2)

Publication Number Publication Date
CN110331121A true CN110331121A (en) 2019-10-15
CN110331121B CN110331121B (en) 2021-01-05

Family

ID=68142709

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910549289.5A Active CN110331121B (en) 2019-06-24 2019-06-24 Recombinant bacterium for high-yield lipopeptide and application thereof

Country Status (1)

Country Link
CN (1) CN110331121B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103898038A (en) * 2014-03-28 2014-07-02 清华大学 Engineering bacterium for highly expressing lipopeptide biosurfactant and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103898038A (en) * 2014-03-28 2014-07-02 清华大学 Engineering bacterium for highly expressing lipopeptide biosurfactant and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
QUN WU ET AL.: "Systematically engineering the biosynthesis of a green biosurfactant surfactin by Bacillus subtilis 168", 《METABOLIC ENGINEERING》 *

Also Published As

Publication number Publication date
CN110331121B (en) 2021-01-05

Similar Documents

Publication Publication Date Title
CN101631856B (en) Arabinose isomerase expressed from corynebacterium genus and tagatose manufacturing method by using it
CN1914330B (en) Process for large scale production of plasmid DNA by e. coli fermentation
CN105671010A (en) Aldehyde ketone reductase mutant, gene, engineering bacterium and application of mutant
CN113621631A (en) Mevalonate kinase gene RKMK and application thereof
CN107916283B (en) A kind of production technology of niacinamide
CN105861536B (en) The preparation method and application of self-induction enhanced type trehalose synthase synthesis engineering bacteria
CN112280795A (en) Use of glycosyltransferase genes
CN109055327A (en) Aldehyde Ketoreductase mutant and its application
CN105420154A (en) Double knockout recombinant rhodococcus as well as construction method and application thereof
CN107603937A (en) A kind of recombination bacillus coli and its construction method for expressing lysine aminopeptidase
CN103131721A (en) Nucleotide sequence of D-tagatose-3-epimerase (DTE) of ruminococcus sp. and use thereof
CN108315288A (en) A kind of recombination bacillus coli and its construction method and the application of expression formamidase and phosphorous acid dehydrogenase fusion proteins
CN104968794A (en) Process for producing gougerotin employing streptomyces microflavus strains
CN101463358B (en) Nitrile hydratase gene cluster and use thereof
US20230265411A1 (en) Strain Producing D-allulose 3-epimerase and Application thereof
CN101636491A (en) Food grade thermophilic arabinose isomerase expressed from gras, and tagatose manufacturing method by using it
CN115011616A (en) Acetaldehyde dehydrogenase gene RKALDH and application thereof
CN101691560B (en) Colibacillus and method for performing soluble expression of transglutaminase proenzyme thereof
CN109486734A (en) A kind of genetic engineering bacterium producing chondroitin and its construction method and application
CN116478878A (en) Bacillus subtilis for high-yield riboflavin and application thereof
CN110343709A (en) A kind of arctic nocardia lasso trick peptide gene cluster and its cloning and expression method
CN109576239A (en) Heat-resisting phosphorylase and its application
CN111411066B (en) Double-way composite neuraminic acid-producing bacillus subtilis and construction method thereof
CN110283800B (en) Glucose oxidation enzyme mutant, double enzyme coexpression vectors and its application
CN110331121A (en) A kind of recombinant bacterium of high yield lipopeptid and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant